Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...

Multiple myeloma starts in the plasma cells inside your bone marrow. People with multiple myeloma have high levels of certain proteins in their blood and urine. An oncologist (a medical doctor ...

The mother of a seven-year-old with a life-threatening blood disorder says despite treatments being the same as cancer, they ...

For four decades, Ohio State blood and bone marrow transplant innovation has improved cancer care with an increasing emphasis ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for ...

2 Today, treatment for multiple myeloma often involves an intensive combination of chemotherapy, steroids, immunomodulatory drugs, and bone marrow transplants to slow down this multiplication and ...

As time progressed, new drug therapies (as well as stem-cell transplant treatment ... is the primary bodily system impacted by multiple myeloma. Bone marrow is a spongy, soft tissue with the ...

Multiple myeloma is a cancer involving plasma cells ... is in remission after six months of chemotherapy and a bone marrow transplant. He manages the disease by taking a daily chemotherapy pill.

Bone marrow transplant is associated with accelerated brain aging and worse neurocognitive functioning, data suggest.

The facility of bone marrow transplant is not available for ... chronic lymphoid leukaemia, multiple myeloma, diffuse large B-cell lymphoma, Hodgkin's lymphoma, myelodysplastic syndrome ...

Ciltacabtagene autoleucel improved minimal residual disease negativity and sustained responses vs standard care in ...